Avestar Capital’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,180
Closed -$367K 452
2021
Q1
$367K Buy
3,180
+93
+3% +$10.1K 0.08% 215
2020
Q4
$311K Buy
3,087
+362
+13% +$33.6K 0.09% 204
2020
Q3
$231K Buy
+2,725
New +$205K 0.08% 196
2019
Q3
Sell
-2,014
Closed -$139K 368
2019
Q2
$139K Buy
2,014
+48
+2% +$3.65K 0.09% 147
2019
Q1
$132K Buy
1,966
+136
+7% +$10.8K 0.09% 157
2018
Q4
$112K Sell
1,830
-454
-20% -$36.2K 0.08% 166
2018
Q3
$201K Buy
2,284
+453
+25% +$44.9K 0.12% 118
2018
Q2
$166K Buy
1,831
+55
+3% +$5.81K 0.11% 130
2018
Q1
$172K Buy
1,776
+262
+17% +$26.5K 0.11% 105
2017
Q4
$129K Buy
+1,514
New +$138K 0.1% 127

Other funds holding EMN

Avestar Capital's EMN Position: Q2 2021 in Review

Avestar Capital sold out of Eastman Chemical (EMN) in Q2 2021, closing a stake of 3,180 shares — an estimated $367K sold.

Avestar Capital first reported a position in EMN in Q4 2017 and held it in 10 quarters. The position peaked at $367K in Q1 2021. 724 funds tracked by Wall St. Rank hold EMN as of Q2 2021.

  • Avestar Capital reported no remaining Eastman Chemical position as of Q2 2021 after selling out during the quarter.
  • Avestar Capital sold 3,180 Eastman Chemical shares in Q2 2021, an estimated $367K.
  • Avestar Capital first reported a position in Eastman Chemical in Q4 2017 and held it in 10 quarters.
  • Avestar Capital's Eastman Chemical position peaked at $367K in Q1 2021.
  • 724 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2021.

Based on Avestar Capital's 13F filing for Q2 2021, filed 3 Aug 2021.